Trials / Completed
CompletedNCT03126201
Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis
Predictors of Disease Progression in Patients With Primary Focal Segmental Glomerulosclerosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 86 (actual)
- Sponsor
- Istanbul University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Focal segmental glomerulosclerosis (FSGS) is one of the most common primary glomerular diseases leading to end stage renal disease. In this study, our aim is to evaluate the effects of histopathological, clinical, and laboratory features of patients with primary FSGS on the disease progression.
Detailed description
Focal segmental glomerulosclerosis (FSGS) is one of the most common primary glomerular diseases leading to end stage renal disease worldwide. Numerous studies have been conducted in order to identify the etiology of this debilitating disease. Beyond the etiological research, however, few studies managed to demonstrate the possible predictors of disease progression in patients. Therefore, we aim to evaluate the effects of histopathological, clinical, and laboratory features of patients with primary FSGS on the disease progression.
Conditions
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-09-01
- Completion
- 2017-11-01
- First posted
- 2017-04-24
- Last updated
- 2018-02-19
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03126201. Inclusion in this directory is not an endorsement.